These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8484635)

  • 21. Concurrent blockade of platelet-activating factor and histamine prevents life-threatening peanut-induced anaphylactic reactions.
    Arias K; Baig M; Colangelo M; Chu D; Walker T; Goncharova S; Coyle A; Vadas P; Waserman S; Jordana M
    J Allergy Clin Immunol; 2009 Aug; 124(2):307-14, 314.e1-2. PubMed ID: 19409603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of WEB 2086, a novel antagonist of platelet activating factor, in active and passive anaphylaxis.
    Casals-Stenzel J
    Immunopharmacology; 1987 Apr; 13(2):117-24. PubMed ID: 3597059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of hetrazepine PAF antagonists in preclinical models of asthma.
    Heuer HO
    Agents Actions Suppl; 1991; 34():229-45. PubMed ID: 1793067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. WEB 2347: pharmacology of a new very potent and long acting hetrazepinoic PAF-antagonist and its action in repeatedly sensitized guinea-pigs.
    Heuer HO
    J Lipid Mediat; 1991; 4(1):39-44. PubMed ID: 1893086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The action of platelet activating factor and its antagonism by WEB 2086 on human isolated airways.
    Johnson PR; Armour CL; Black JL
    Eur Respir J; 1990 Jan; 3(1):55-60. PubMed ID: 2311732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of active anaphylaxis in mice and guinea pigs by the new hetrazepinoic PAF antagonist bepafant (WEB 2170).
    Heuer HO
    Eur J Pharmacol; 1991 Jun; 199(2):157-63. PubMed ID: 1954975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of H1- and H2-antihistamines on platelet-activating factor and bradykinin-induced inflammatory responses in human skin.
    Sansom JE; Brooks J; Burton JL; Archer CB
    Clin Exp Dermatol; 1996 Jan; 21(1):33-7. PubMed ID: 8689766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of PAF-induced histamine secretion and bronchoconstriction by WEB 2086.
    Chand N; Pillar J; Nolan K; Diamantis W; Sofia RD
    Res Commun Chem Pathol Pharmacol; 1990 Jan; 67(1):155-8. PubMed ID: 1691522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of the actions of platelet activating factor (PAF) antagonists WEB 2170 and WEB 2086 in the horse.
    Foster AP; Cunningham FM; Andrews MJ; Lees P
    J Vet Pharmacol Ther; 1993 Dec; 16(4):477-87. PubMed ID: 8126765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of the hetrazepinoic platelet-activating factor antagonist Bepafant (WEB 2170) in models of active and passive anaphylaxis in mice and guinea pigs.
    Heuer HO
    Lipids; 1991 Dec; 26(12):1374-80. PubMed ID: 1819736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IgE-induced respiratory and circulatory changes during systemic anaphylaxis in the rabbit.
    Halonen M; Fisher HK; Blair C; Butler C; Pinckard RN
    Am Rev Respir Dis; 1976 Nov; 114(5):961-70. PubMed ID: 984586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet-activating factor and bacteremia-induced pulmonary hypertension.
    Clavijo LC; Carter MB; Matheson PJ; Wills-Frank LA; Wilson MA; Wead WB; Garrison RN
    J Surg Res; 2000 Feb; 88(2):173-80. PubMed ID: 10644485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
    Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B
    Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet-activating factor (PAF) mediation of rat anaphylactic responses to soluble immune complexes. Studies with PAF receptor antagonist L-652,731.
    Doebber TW; Wu MS; Biftu T
    J Immunol; 1986 Jun; 136(12):4659-68. PubMed ID: 3011900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor.
    Heuer HO; Casals-Stenzel J; Muacevic G; Weber KH
    J Pharmacol Exp Ther; 1990 Dec; 255(3):962-8. PubMed ID: 2262914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of a novel PAF antagonist, E6123, on passive anaphylaxis.
    Sakuma Y; Tsunoda H; Katayama S; Harada K; Obaishi H; Shirato M; Yamada K; Miyazawa S; Okano K; Machida Y
    Agents Actions Suppl; 1990; 31():255-8. PubMed ID: 2080758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological actions of Y-24180: I. A potent and specific antagonist of platelet-activating factor.
    Terasawa M; Aratani H; Setoguchi M; Tahara T
    Prostaglandins; 1990 Dec; 40(6):553-69. PubMed ID: 2093935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of the selective PAF antagonist WEB 2170 on PAF and antigen induced airway hyperresponsiveness and eosinophil infiltration.
    Seeds EA; Coyle AJ; Page CP
    J Lipid Mediat; 1991; 4(1):111-21. PubMed ID: 1893085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of the PAF-antagonist WEB 2086 on anaphylactic lung reaction: comparison of inhalative and intravenous challenge.
    Heuer H; Casals-Stenzel J
    Agents Actions Suppl; 1988; 23():207-15. PubMed ID: 3262991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Basophil-derived platelet-activating factor (PAF) as an in vivo mediator of acute allergic reactions: demonstration of specific desensitization of platelets to PAF during IgE-induced anaphylaxis in the rabbit.
    Henson PM; Pinckard RN
    J Immunol; 1977 Dec; 119(6):2179-84. PubMed ID: 915294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.